| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 13 |
| 1 | ATEZOLIZUMAB | 11 |
| 2 | PEMBROLIZUMAB | 8 |
| 3 | AMLODIPINE BESYLATE | 5 |
| 4 | EZETIMIBE | 4 |
| 5 | AMLODIPINE | 3 |
| 6 | ASPIRIN | 3 |
| 7 | ASPIRIN 325 MG | 3 |
| 8 | ASPIRIN 81 MG | 3 |
| 9 | LANSOPRAZOLE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0011 |
| 1 | MIGLITOL | 1 | 0.0010 |
| 2 | RISDIPLAM | 3 | 0.0007 |
| 3 | NIZATIDINE | 1 | 0.0007 |
| 4 | SENNOSIDES A AND B | 1 | 0.0006 |
| 5 | RILUZOLE | 1 | 0.0004 |
| 6 | FINERENONE | 1 | 0.0003 |
| 7 | ATEZOLIZUMAB | 11 | 0.0003 |
| 8 | ROPINIROLE HYDROCHLORIDE | 1 | 0.0003 |
| 9 | ENFORTUMAB VEDOTIN | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 3 | 0.0007 |
| 1 | Benzothiazole [EPC] | 1 | 0.0004 |
| 2 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 20 | 0.0002 |
| 4 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Glinide [EPC] | 1 | 0.0001 |
| 7 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 9 | Bile Acid [EPC] | 2 | 0.0001 |